Waters [WAT] vs Idexx Laboratories [IDXX] Detailed Stock Comparison

Waters Corporation

NYSE
Loading...

Idexx Laboratories, Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Waters Corporation wins in 10 metrics, Idexx Laboratories, Inc. wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric Waters Corporation Idexx Laboratories, Inc. Better
P/E Ratio (TTM) 28.90 42.92 Waters Corporation
Price-to-Book Ratio 7.24 27.85 Waters Corporation
Debt-to-Equity Ratio 60.28 60.83 Waters Corporation
PEG Ratio -9.39 2.41 Idexx Laboratories, Inc.
EV/EBITDA 28.78 31.12 Waters Corporation
Profit Margin (TTM) 20.30% 24.62% Idexx Laboratories, Inc.
Operating Margin (TTM) 33.76% 29.76% Waters Corporation
EBITDA Margin (TTM) 33.76% 29.76% Waters Corporation
Return on Equity 29.28% 66.20% Idexx Laboratories, Inc.
Return on Assets (TTM) 11.52% 25.59% Idexx Laboratories, Inc.
Free Cash Flow (TTM) $539.81M $1.04B Idexx Laboratories, Inc.
1-Year Return 3.87% 7.30% Idexx Laboratories, Inc.
Price-to-Sales Ratio (TTM) 9.65 10.38 Waters Corporation
Enterprise Value $31.49B $46.85B Idexx Laboratories, Inc.
EV/Revenue Ratio 9.95 10.89 Waters Corporation
Gross Profit Margin (TTM) 61.08% 60.35% Waters Corporation
Revenue per Share (TTM) $53 $54 Idexx Laboratories, Inc.
Earnings per Share (Diluted) $10.77 $13.07 Idexx Laboratories, Inc.
Beta (Stock Volatility) 1.20 1.72 Waters Corporation
Short % of Float 3.38% 2.74% Idexx Laboratories, Inc.

Waters Corporation vs Idexx Laboratories, Inc. Stock Performance Analysis

Loading Price Chart...

WAT
IDXX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Waters Corporation0.63%-1.54%8.67%23.36%-7.18%-6.34%
Idexx Laboratories, Inc.1.63%1.57%7.79%-2.79%-18.64%-14.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Waters Corporation3.87%32.07%3.74%165.28%286.07%736.74%
Idexx Laboratories, Inc.7.30%16.12%-6.68%539.84%1,431.62%2,795.61%

Performance & Financial Health Analysis: Waters Corporation vs Idexx Laboratories, Inc.

MetricWATIDXX
Market Information
Market Cap i$30.55B$44.66B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i809,747480,502
90 Day Avg. Volume i944,136516,114
Last Close$357.76$570.00
52 Week Range$275.05 - $414.15$506.91 - $769.98
% from 52W High-13.62%-25.97%
All-Time High$428.22 (Sep 06, 2021)$769.98 (Nov 26, 2025)
% from All-Time High-16.45%-25.97%
Growth Metrics
Quarterly Revenue Growth0.07%0.14%
Quarterly Earnings Growth-0.03%0.15%
Financial Health
Profit Margin (TTM) i0.20%0.25%
Operating Margin (TTM) i0.34%0.30%
Return on Equity (TTM) i0.29%0.66%
Debt to Equity (MRQ) i60.2860.83
Cash & Liquidity
Book Value per Share (MRQ)$43.01$20.14
Cash per Share (MRQ)$5.99$2.26
Operating Cash Flow (TTM) i$652.56M$1.18B
Levered Free Cash Flow (TTM) i$427.16M$790.74M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Waters Corporation vs Idexx Laboratories, Inc.

MetricWAT (Apr 24, 2026)IDXX (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i28.9042.92
Forward P/E i19.0434.19
PEG Ratio i-9.392.41
Price to Sales (TTM) i9.6510.38
Price to Book (MRQ) i7.2427.85
Market Capitalization
Market Capitalization i$30.55B$44.66B
Enterprise Value i$31.49B$46.85B
Enterprise Value Metrics
Enterprise to Revenue i9.9510.89
Enterprise to EBITDA i28.7831.12
Risk & Other Metrics
Beta i1.201.72
Book Value per Share (MRQ) i$43.01$20.14

Financial Statements Comparison: Waters Corporation vs Idexx Laboratories, Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricWAT (2025)IDXX (2025)
Revenue/Sales i3.17B4.30B
Cost of Goods Sold i1.29B1.64B
COGS % of Revenue i40.7%38.2%
Gross Profit i1.88B2.66B
Gross Margin i59.3%61.8%
Research & Development i195.71M251.21M
Operating Income (EBIT) i802.59M1.36B
Operating Margin i25.4%31.6%
EBITDA i1.03B1.51B
EBITDA Margin i32.6%35.0%
Pre-Tax Income i754.88M1.32B
Pre-Tax Income % of Revenue i23.8%30.8%
Income Tax i112.25M264.73M
Income Tax % of Revenue i3.5%6.2%
Net Income (Profit) i642.63M1.06B
Profit Margin i20.3%24.6%

Balance Sheet & Liquidity Metrics

MetricWAT (2025)IDXX (2025)
Cash & Equivalents i587.83M180.07M
Total Current Assets i2.15B1.41B
Total Current Assets % of Revenue i67.8%32.9%
Total Current Liabilities i1.24B1.15B
Total Current Liabilities % of Revenue i39.2%26.7%
Long-Term Debt i999.99M475.99M
Long-Term Debt % of Revenue i31.6%11.1%
Total Shareholders Equity i2.56B1.61B
Retained Earnings i10.43B6.39B
Retained Earnings % of Revenue i329.6%148.5%
Property, Plant & Equipment i824.49M123.23M

Cash Flow Statement Comparison

MetricWAT (2025)IDXX (2025)
Operating Cash Flow i652.56M1.17B
Operating Cash Flow % of Revenue i20.6%27.3%
Capital Expenditures i-112.75M-124.68M
Free Cash Flow i539.81M1.04B
FCF Margin i17.1%24.2%
Debt Repayment i-290.00M-428.39M
Common Stock Repurchase i-14.67M-1.22B

Short Interest & Institutional Ownership Analysis

MetricWATIDXX
Shares Short i3.32M1.91M
Short Ratio i2.983.85
Short % of Float i3.38%2.74%
Shares Outstanding i59.55M79.71M
Float Shares i97.96M78.75M
% Held by Insiders i0.11%0.71%
% Held by Institutions i63.35%96.04%
% Held by Public i36.54%3.25%

Dividend Analysis & Yield Comparison: Waters Corporation vs Idexx Laboratories, Inc.

MetricWATIDXX
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i$0.00N/A
Ex-Dividend DateN/AN/A